Nanosonics receives US FDA clearance for next-generation disinfection technology
Infection prevention company Nanosonics has received US Food and Drug Administration clearance for its latest trophon innovation, enabling the commercial launch of trophon3 and trophon2 Plus in the United States, according to an announcement on Tuesday. The new trophon3 technology delivers over 40 per cent faster cycle times compared to previous generations whilst maintaining the…